Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Trends Cardiovasc Med. 2014 Jun 12;24(6):232–240. doi: 10.1016/j.tcm.2014.06.002

Figure 3.

Figure 3

TACT Kaplan-Meier Estimates of the Primary Composite Endpoint EDTA Chelation Therapy vs. Placebo Subset of Patients with Diabetes: Hx, Med Use or Baseline Glucose>=126

Adapted with permission from

Circulation: Cardiovascular Quality Outcomes:

“Escolar E, Lamas G a, Mark DB, Boineau R, Goertz C, Rosenberg Y, et al. The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT). Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):15–24.”